Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

NCT01920945 is registered in ClinicalTrials.gov with St. Luke's-Roosevelt Hospital Center as lead sponsor.

NCT NCT01920945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01920945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study
Lead sponsor
St. Luke's-Roosevelt Hospital Center
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2014
Completion date
October 31, 2016
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

new daily persistent headache